Mei Wang
biotech focusing on world leading r&d to solve unmet medical needs
dizal pharmaceutical
team leaderDr. Duan Wang
Hengrui is the largest pharmaceutical company based in China by market cap (around 90 billion USD) and among the top ones by revenue and R&D spending (3.28b USD and 549m USD in 2019, respectively). 5+ differentiated products in global clinical development with commercial rights available for discussions.
Jiangsu Hengrui Pharma
Associate Director of BDgrace wang
DENTAL MATERIALS
STENTS
EPIDEMIC PREVENTION PRODUCTS ETC.
STENTS
EPIDEMIC PREVENTION PRODUCTS ETC.
Beijing ATMbiomaterials Co., Ltd
MDMr. Jason Wang
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration and diabetic macular edema. For more information, please visit www.adverum.com.
Adverum Biotechnologies
Associate Director StrategyMr. Jibo Wang
An international enterprise dedicated to the innovation, ptoduce and selling of innovative drugs

English (UK)
中文版
Responsive Web Design powered by